UFC's Iasmin Lucindo Benched Nine Months by CSAD After Drug Test Failure
Briefly

UFC's Iasmin Lucindo Benched Nine Months by CSAD After Drug Test Failure
"In a recent press release, CSAD officials announced that Brazil's Lucindo (18-6), 24, had tested positive for mesterolone, a substance banned at all times by the UFC's Anti-Doping Policy as administered by CSAD. Lucindo's positive test dates back to an out-of-competition sample collected on September 24, 2025, in Feira de Santana, Brazil. Her suspension is backdated accordingly. Documentation provided by Lucindo revealed the possibility of a contaminated supplement, per the CSAD's press release."
"Lucindo tested negative in August 2025, with low levels of mesterolone turning up in her September sample. The fighter was able to provide investigators with official government documentation from a Brazilian pharmacy where she obtained compounded dietary supplements. The circumstances surrounding Lucindo's positive test saw her period of ineligibility reduced from a possible one year, to nine months. She'll be eligible to return to action on June 24, 2026."
Iasmin Lucindo tested positive for mesterolone in an out-of-competition sample collected on September 24, 2025, in Feira de Santana, Brazil. CSAD imposed a nine-month suspension backdated to the sample collection date. Documentation provided by Lucindo suggested a contaminated supplement as the likely source, and she had a negative test in August 2025 while low levels appeared in the September sample. Lucindo submitted official government documentation from a Brazilian pharmacy showing acquisition of compounded dietary supplements. The suspension was reduced from a possible one year to nine months because of the circumstances. She is eligible to return on June 24, 2026, and was removed from a scheduled fight with Gillian Robertson. Lucindo is 18-6, 24 years old, ranked #7 at 115lb, and has a 5-1 record in her last six fights, most recently defeating Angela Hill.
Read at Cageside Press
Unable to calculate read time
[
|
]